Lori McNeill insider trades

Open-market stock purchases and sales by Lori McNeill, Director at Sonnet BioTherapeutics Holdings, Inc, from SEC Form 4 filings since Dec 14, 2022.

Recent trades

DateStockTradeValue
Dec 2, 2025SONN Sonnet BioTherapeutics Holdings, IncSold (not open market)—

Companies traded

  • SONN Sonnet BioTherapeutics Holdings, Inc: other filings, last Dec 2, 2025

Get free alerts when Lori McNeill files a new trade →